$GNW

Genworth Financial (GNW) responded to a UK Court of Appeal ruling against AXA in a case involving Santander, related to mis-sold Payment Protection Insurance (PPI) policies. The court found Santander not liable for most of AXA's losses. Genworth, which sold the policies to AXA in 2015, stated it remains focused on its strategic priorities and has not factored any recoveries from the case into its capital plans. The company is evaluating next steps, including potential appeals.

Genworth Financial (GNW) increased its share buyback authorization by $500M, bringing total unused capacity to $588M. The move relies on capital returns from its majority-owned subsidiary, Enact Holdings (ACT), which has raised its expected 2026 capital returns to $550M-$600M. GNW has already repurchased 30M shares for $262M under the prior authorization. However, the company faces risks, including dependence on ACT's performance and legacy insurance challenges.

McInerney Thomas J (President and CEO; Director) sold 100,000 shares of GENWORTH FINANCIAL INC (GNW) at $10.53 ($1.05M total) on 2026-09-03.

Genworth Financial (GNW) shareholder Thomas J. McInerney plans to sell 100,000 shares, valued at $1.05M, under Rule 144. The shares were acquired as restricted stock compensation and vest on March 2, 2026. The sale is managed by Fidelity Brokerage Services.

Genworth Financial (GNW) announced CEO Thomas J. McInerney will return on September 2, 2026. Shares trade at $9.94, up 16.67% over 90 days and 15.99% over a year. The P/E ratio of 18.6x is above industry and peer averages, with earnings declining 3.3% over the past year and 40.5% annually over five years. Analysts have a target price of $12.00.

Hagerman Melissa (EVP and Chief HR Officer) sold 14,708 shares of GENWORTH FINANCIAL INC (GNW) at $9.92 ($0.15M total) on 2026-08-24.

Karawan Gregory S. (EVP and General Counsel) sold 40,000 shares of GENWORTH FINANCIAL INC (GNW) at $9.91 ($0.40M total) on 2026-08-21.

GENWORTH FINANCIAL INC (GNW) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 20, 2026, Genworth Financial, Inc. (the “Company”) announced that Thomas J. McInerney will return from a leave of

Genworth Financial (GNW) reported Q2 2026 net income of $47 million, down from $51 million a year earlier, with EPS broadly stable, and continued a large share repurchase program. The article says Enact mortgage insurance generated strong adjusted operating income and Genworth raised 2026 buyback guidance, citing its ~81% Enact stake and capital recycling into repurchases and CareScout.

Genworth Financial reported Q2 net income of $47 million and said it is relying on mortgage insurance Enact and its CareScout aging-care platform to offset long-term care insurance liabilities. CareScout had 1,450 matches in Q2 and expects about $25 million in 2026 CareScout Services revenue. Enact guidance implies $445M to $485M capital returns in 2026. Genworth’s AXA appeal decision is expected in 3 to 6 months.